Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024

Rhea-AI Summary

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) will be presenting at the RBC Capital Markets Global Healthcare Conference on May 14, 2024. The presentation is scheduled for 8:00 a.m. ET and will focus on the company's innovative therapies for rare diseases. Investors can access the live webcast on the company's website and a replay will be available for two weeks after the event.

CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. ET.

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. A replay of the webcast will be archived on the company’s website for at least two weeks following the presentation.

About Agios
Agios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In the U.S., Agios markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for this rare, lifelong, debilitating hemolytic anemia. Building on the company's deep scientific expertise in classical hematology and leadership in the field of cellular metabolism and rare hematologic diseases, Agios is advancing a robust clinical pipeline of investigational medicines with programs in alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency, MDS-associated anemia and phenylketonuria (PKU). In addition to its clinical pipeline, Agios is advancing a preclinical TMPRSS6 siRNA as a potential treatment for polycythemia vera. For more information, please visit the company’s website at www.agios.com.

Contacts:

Investor Contact
Chris Taylor, VP, Investor Relations and Corporate Communications
Agios Pharmaceuticals
IR@agios.com

Media Contact
Dan Budwick
1AB
dan@1abmedia.com  

FAQ

When will Agios Pharmaceuticals present at the RBC Capital Markets Global Healthcare Conference?

Agios Pharmaceuticals will present on May 14, 2024.

What time is the presentation scheduled?

The presentation is scheduled for 8:00 a.m. ET.

Where can investors access the live webcast?

Investors can access the live webcast on Agios Pharmaceuticals' website.

Will there be a replay available after the presentation?

Yes, a replay will be archived on the company's website for at least two weeks following the presentation.